Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug 3;13(15):2589.
doi: 10.3390/diagnostics13152589.

Autoimmune Encephalitis with Antibodies: Anti-NMDAR, Anti-AMPAR, Anti-GQ1b, Anti-DPPX, Anti-CASPR2, Anti-LGI1, Anti-RI, Anti-Yo, Anti-Hu, Anti-CV2 and Anti-GABAAR, in the Course of Psychoses, Neoplastic Diseases, and Paraneoplastic Syndromes

Affiliations
Review

Autoimmune Encephalitis with Antibodies: Anti-NMDAR, Anti-AMPAR, Anti-GQ1b, Anti-DPPX, Anti-CASPR2, Anti-LGI1, Anti-RI, Anti-Yo, Anti-Hu, Anti-CV2 and Anti-GABAAR, in the Course of Psychoses, Neoplastic Diseases, and Paraneoplastic Syndromes

Michał Braczkowski et al. Diagnostics (Basel). .

Abstract

Encephalitis is a condition with a variety of etiologies, clinical presentations, and degrees of severity. The causes of these disorders include both neuroinfections and autoimmune diseases in which host antibodies are pathologically directed against self-antigens. In autoimmune encephalitis, autoantibodies are expressed in the central nervous system. The incidence of this disease is approximately 4% of all reported cases of encephalitis. Autoimmune encephalitis can be induced by antibodies against neuronal surface antigens such as N-methyl-D-aspartate-activated glutamate receptors (NMDAR), α-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptors (AMPAR) or gangliosides GQ1b, DPPX, CASPR2, LGI1, as well as by antibodies against neuronal intracellular antigens. The paper presents a number of both mental and neurological symptoms of autoimmune encephalitis. Moreover, the coexistence of psychoses, neoplastic diseases, and the methods of diagnosing autoimmune encephalitis are discussed. Attention was also drawn to the fact that early diagnosis, as well as early initiation of targeted treatment, increases the chance of a successful course of the therapeutic process. Strategy and Methodology: The articles on which the following paper was based were searched using search engines such as PubMed and Medline. Considering that anti-NMDAR antibodies were first described in 2007, the articles were from 2007 to 2023. The selection of papers was made by entering the phrases "autoimmune encephalitis and psychosis/paraneplastic syndromes or cancer". The total number of articles that could be searched was 747, of which 100 items were selected, the most recent reports illustrating the presented topic. Thirty-four of them were rejected in connection with case reports or papers that could not be accessed.

Keywords: anti-AMPAR antibodies; anti-CASPR2 antibodies; anti-DPPX antibodies; anti-GQ1b antibodies; anti-LGI1 antibodies; anti-NMDAR antibodies; autoimmune inflammation with antibodies; encephalitis; psychoses.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Distribution of antigen in cellular.
Figure 2
Figure 2
Incidence of particular antibodies.

References

    1. Gałecki P., Szulc A. Psychiatry. Edra Urban & Partner; Wroclaw, Poland: 2018. p. 159.
    1. Gałecki P. Mental State Examination, ICD-11 Criteria. Edra Urban & Partner; Wroclaw, Poland: 2022. pp. 63–88.
    1. Granerod J., Ambrose H.E., Davies N.W., Clewley J.P., Walsh A.L., Morgan D., Cunningham R., Zuckerman M., Mutton K.J., Solomon T., et al. Causes of encephalitis and differences in their clinical presentations in England: A multicentre, population-based prospective study. Lancet Infect. Dis. 2010;10:835–844. doi: 10.1016/S1473-3099(10)70222-X. - DOI - PubMed
    1. Alloza C., Blesa-Cábez M., Bastin M.E., Madole J.W., Buchanan C.R., Janssen J., Gibson J., Deary I.J., Tucker-Drob E.M., Whalley H.C., et al. Psychotic-like experiences, polygenic risk scores for schizophrenia, and structural properties of the salience, default mode, and central-executive networks in healthy participants from UK Biobank. Transl. Psychiatry. 2020;10:122. doi: 10.1038/s41398-020-0794-x. - DOI - PMC - PubMed
    1. Julayanont P., Suryadevara U. Psychosis. Contin. (Minneap. Minn.) 2021;27:1682–1711. doi: 10.1212/CON.0000000000001013. - DOI - PubMed

LinkOut - more resources